| Stochastic frontier analysis using Stata F Belotti, S Daidone, G Ilardi, V Atella The Stata Journal 13 (4), 719-758, 2013 | 667 | 2013 |
| Trends in age‐related disease burden and healthcare utilization V Atella, A Piano Mortari, J Kopinska, F Belotti, F Lapi, C Cricelli, ... Aging cell 18 (1), e12861, 2019 | 361 | 2019 |
| Mediterraneo del Nord: un'altra idea del Mezzogiorno N Rossi, C Amadei, V Atella Laterza, 2005 | 168 | 2005 |
| The efficiency frontier approach to economic evaluation of health‐care interventions JJ Caro, E Nord, U Siebert, A McGuire, M McGregor, D Henry, ... Health economics 19 (10), 1117-1127, 2010 | 154 | 2010 |
| Are employers discriminating with respect to weight?: European Evidence using Quantile Regression V Atella, N Pace, D Vuri Economics & Human Biology 6 (3), 305-329, 2008 | 147 | 2008 |
| Household portfolio choices, health status and health care systems: A cross-country analysis based on SHARE V Atella, M Brunetti, N Maestas Journal of banking & finance 36 (5), 1320-1335, 2012 | 141 | 2012 |
| Determinants of access to physician services in Italy: a latent class seemingly unrelated probit approach V Atella, F Brindisi, P Deb, FC Rosati Health economics 13 (7), 657-668, 2004 | 128 | 2004 |
| Disease burden and economic impact of diagnosed non‐alcoholic steatohepatitis in five European countries in 2018: a cost‐of‐illness analysis JM Schattenberg, JV Lazarus, PN Newsome, L Serfaty, A Aghemo, ... Liver International 41 (6), 1227-1242, 2021 | 107 | 2021 |
| Prescription drug utilization following patient co‐payment changes in Australia P McManus, N Donnelly, D Henry, W Hall, J Primrose, J Lindner Pharmacoepidemiology and Drug Safety 5 (6), 385-392, 1996 | 83 | 1996 |
| Drug compliance, co‐payment and health outcomes: evidence from a panel of Italian patients V Atella, F Peracchi, D Depalo, C Rossetti Health economics 15 (9), 875-892, 2006 | 81 | 2006 |
| The cost of prescription medicines to patients PR Noyce, C Huttin, V Atella, G Brenner, FM Haaijer-Ruskamp, ... Health Policy 52 (2), 129-145, 2000 | 81 | 2000 |
| Are primary care physicians, public and private sector specialists substitutes or complements? Evidence from a simultaneous equations model for count data V Atella, P Deb Journal of health economics 27 (3), 770-785, 2008 | 79 | 2008 |
| Affordability of medicines and patients’ cost-reducing behaviour: empirical evidence based on SUR estimates from Italy and the UK V Atella, E Schafheutle, P Noyce, K Hassell Applied health economics and health policy 4, 23-35, 2005 | 70 | 2005 |
| Investment and exchange rate uncertainty V Atella, GE Atzeni, PL Belvisi Journal of Policy Modeling 25 (8), 811-824, 2003 | 66 | 2003 |
| Drug cost containment policies in Italy: are they really effective in the long-run?: The case of minimum reference price V Atella Health policy 50 (3), 197-218, 2000 | 62 | 2000 |
| Measuring spatial effects in the presence of institutional constraints: The case of Italian Local Health Authority expenditure V Atella, F Belotti, D Depalo, AP Mortari Regional Science and Urban Economics 49, 232-241, 2014 | 60 | 2014 |
| Do R&D expenditures really matter for TFP? V Atella, B Quintieri Applied Economics 33 (11), 1385-1389, 2001 | 59 | 2001 |
| Generating halton sequences using mata DM Drukker, R Gates The Stata Journal 6 (2), 214-228, 2006 | 56 | 2006 |
| Body weight, eating patterns, and physical activity: The role of education V Atella, J Kopinska Demography 51, 1225-1249, 2014 | 54 | 2014 |
| Cost to the patient or cost to the healthcare system? Which one matters the most for GP prescribing decisions? A UK–Italy comparison K Hassell, V Atella, EI Schafheutle, MC Weiss, PR Noyce The European Journal of Public Health 13 (1), 18-23, 2003 | 52 | 2003 |
Federico BelottiDepartment of Economics and Finance, University of Rome Tor VergataVerifisert e-postadresse på uniroma2.it
